Studies have highlighted the potential of targeting VEGF signaling in osteo-sarcoma, as its inhibition not only reduces angiogenesis but also promotes apoptosis, suggesting a promising therapeutic approach. The gene discussed is VEGFA; the disease is sarcoma.